our data uncovered a significant role of the circCRIM1/miR-513 pathway in the proliferation, migration, and invasion of OS cell lines and suggested that circCRIM1 may serve as a possible therapeutic target for OS treatment.
The circular RNA circCRIM1 inhibits osteosarcoma progression through sponging miR-513.